Clinical trial Recruiting at 1 site Interventional Ages 26 Weeks to 30 Weeks

Optimizing growth and brain development in preterm infants using a robotic device

Official title: Creating a CALMER NICU: Pilot Testing a Robot for Optimizing Growth and Brain Development in Preterm Infants in the NICU

Run by University of British Columbia · NCT04911452 · Data updated 2026-11-12

This study is testing a special therapy bed called Calmer to see if it helps reduce stress and improve growth and brain development in preterm babies in the NICU.

Quick facts

Study typeInterventional
Ages26 Weeks to 30 Weeks
SexAll
Enrollment30 (estimated)
SponsorUniversity of British Columbia
Academic / other
Locations1 site (Vancouver, British Columbia)
StatusRecruiting
StartedSeptember 27, 2021
Main results expectedJune 30, 2025
Study endsDecember 31, 2025
Registry record updatedJanuary 1, 2025
Trial IDNCT04911452 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are preterm infants born at 26-30 weeks gestational age who are admitted to the NICU and require respiratory support.

Probably not a fit

Patients with congenital anomalies, major neurological injuries, or ongoing infections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot trial aims to assess the effectiveness of a prototype therapy bed called Calmer, designed to reduce stress in preterm infants in the neonatal intensive care unit (NICU). The device mimics skin-to-skin care by providing an artificial skin surface, heartbeat sounds, and breathing motion, personalized with recordings from the parents. The study will enroll preterm infants born at 26-30 weeks gestational age and will evaluate the feasibility of implementing this intervention, including patient accrual and adherence to treatment protocols. If successful, the results will inform a larger randomized controlled trial comparing the combined approach of skin-to-skin care and Calmer against skin-to-skin care alone.

Why it matters

Potential benefit: If successful, this approach could significantly improve brain development and reduce stress in preterm infants, leading to better long-term outcomes.

How similar studies have gone: Previous studies have shown promising results with similar approaches to reducing stress in preterm infants, indicating potential for success in this novel intervention.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Preterm infants admitted to the neonatal intensive care unit (NICU) at the British Columbia (BC) Women's Hospital born at 26-30 completed weeks gestational age (GA). GA is determined accurately using early gestation ultrasonogram (standard of care in BC), or calculated using the last menstrual period;
* Infants who are on continuous positive airway pressure or are ventilated;
* At least one parent/caregiver must speak sufficient English to provide consent

Exclusion Criteria:

* Infants who have congenital anomalies, small for GA (per medical admission history), or have a history of maternal abuse of controlled drugs and substances; - Infants with an ongoing infection at the time of enrolment;
* Infants that have pre-existing cardiovascular instability defined by shock/hypotension/need for cardiovascular drugs
* Infants receiving paralytic drugs;
* Infants that have major neurological injury (e.g. hypoxic ischemic encephalopathy, hemorrhage/stroke);
* Infants who are beyond the 30th completed week GA (30 weeks + 6 days) at enrolment.

Where it's running

  • British Columbia Women's Hospital and Health Centre
    Vancouver, British Columbia, Canada
    Recruiting

Study contacts

  • Principal investigator: Liisa Holsti, PhD — The University of British Columbia
  • Study coordinator: Manon Ranger, PhD
  • Email: manon.ranger@ubc.ca
  • Phone: 1-604-827-1382

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.